Vincent Gardès

Vincent Gardès currently works at Amber Implants, as Chief Executive Officer from 2025, Théraclion SA, as Chairman from 2026, and Truffle Capital SAS, as Senior Partner from 2018.
Mr. Gardès also formerly worked at Vexim SA, as Chief Executive Officer & Director from 2015 to 2018, Germitec SA, as Chief Executive Officer & Director, Affluent Medical SA, as Chairman from 2018 to 2020, CR Bard (Spain), as Managing Director, Stryker Spine SAS, as Product Manager, Stryker Orthopaedics Corp., as Product Manager, Medtronic France SAS, as Manager-Business Unit from 2002 to 2007, and Stryker Spain Holding SL, as Manager-Sales & Marketing from 1996 to 1999.
Mr. Gardès received his undergraduate degree from Institut Des Etudes Economiques Et Commerciales.